Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections -- Qualified Infectious ...
Lead clinical candidate CTX-187 is a novel antimicrobial immunotherapy developed to treat clinically-prevalent and multi-drug resistant Gram-negative bacterial infections Qualified Infectious Disease ...
WHO releases new target product profiles for urgently needed antibiotics: Geneva Thursday, March 12, 2026, 09:00 Hrs [IST] The World Health Organization (WHO) published three new ...
Drugmakers must focus on developing new antibiotics to fight hospital “superbugs” including meningitis and other infections that can resist last-line treatments, the World Health Organization (WHO) ...
We need a reliable pipeline with new antibacterial agents that are innovative, affordable, accessible to all those who need ...
Daily Democrat on MSN
Precision is key to reducing antibiotic use on dairies
When cows develop mastitis, dairies often respond with immediate antibiotic treatment. That approach has long protected animal health and milk production. But research suggests treating every case the ...
Emerging studies suggest postbiotics could aid PCOS management by restoring gut microbiome balance and enhancing insulin sensitivity and hormonal regulation.
Although a number of studies have found that a diabetes drug called metformin reduces the risk of long COVID, new research finds that it does not reduce symptoms of the condition.
Two live bird markets, 1 in Orange County, Florida, and 1 in Kings County, New York, reported bird flu outbreaks.
EL MUNDO on MSN
The use of certain antibiotics leaves a mark on the intestinal microbiota that lasts between four and eight years after taking them
A study of about 15,000 adults finds a lasting association between the use of certain antibiotics and the balance of the intestinal microbiota. The intestinal microbiota, that community of bacteria ...
FDA and HHS officials have publicly attacked Uniqure, the biotech company seeking approval for a Huntington’s disease treatment, and accused it of lying about requests made by the FDA for additional ...
Scientists have created a genomic blueprint for Aeromonas bacteria, which can cause antibiotic-resistant diarrheal disease—with symptoms often misidentified as cholera—in humans and animals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results